Last update 11 Jun 2025

DR-0202

Overview

Basic Info

Drug Type
Bispecific antibody
Synonyms-
Target-
Action-
Mechanism-
Therapeutic Areas
NeoplasmsDigestive System DisordersEndocrinology and Metabolic Disease+ [3]
Active Indication
Castration-Resistant Prostatic CancerEndometrial CarcinomaGastrooesophageal junction cancer+ [8]
Inactive Indication-
Originator Organization
Dren Bio, Inc.Dren Bio, Inc.
Active Organization
Dren Bio, Inc.Dren Bio, Inc.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with DR-0202
NCT06999187
/ RecruitingPhase 1
A Phase 1a/1b, Multicenter, Open-label, Dose Escalation/Expansion, Multiple-dose Study to Evaluate the Safety and Activity of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
100 Clinical Results associated with DR-0202
Login to view more data
100 Translational Medicine associated with DR-0202
Login to view more data
100 Patents (Medical) associated with DR-0202
Login to view more data
100 Deals associated with DR-0202
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Castration-Resistant Prostatic CancerPhase 1
United States
Dren Bio, Inc.Dren Bio, Inc.
03 Jun 2025
Endometrial CarcinomaPhase 1
United States
Dren Bio, Inc.Dren Bio, Inc.
03 Jun 2025
Gastrooesophageal junction cancerPhase 1
United States
Dren Bio, Inc.Dren Bio, Inc.
03 Jun 2025
HER2-negative breast cancerPhase 1
United States
Dren Bio, Inc.Dren Bio, Inc.
03 Jun 2025
Non-Small Cell Lung CancerPhase 1
United States
Dren Bio, Inc.Dren Bio, Inc.
03 Jun 2025
Ovarian Epithelial CarcinomaPhase 1
United States
Dren Bio, Inc.Dren Bio, Inc.
03 Jun 2025
Pancreatic Ductal AdenocarcinomaPhase 1
United States
Dren Bio, Inc.Dren Bio, Inc.
03 Jun 2025
Squamous Cell Carcinoma of Head and NeckPhase 1
United States
Dren Bio, Inc.Dren Bio, Inc.
03 Jun 2025
Triple Negative Breast CancerPhase 1
United States
Dren Bio, Inc.Dren Bio, Inc.
03 Jun 2025
Urothelial Carcinoma of the Urinary BladderPhase 1
United States
Dren Bio, Inc.Dren Bio, Inc.
03 Jun 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free